Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2648-2655

  Lembo, Giuseppe ^a,e   Rockman, Howard A ^a   Hunter, John J ^a   Steinmetz, Hope ^d   Koch, Walter J ^c   Ma, Lan ^b   Prinz, Morton P ^b   Ross Jr , John ^a   Chien, Kenneth R ^a   Powell Braxton, Lyn ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENENTECH INC   (United States)

^e Department of Medicine   (Italy)

Author keywords

adrenergic receptors; hypertension; insulin like growth factor I; mutagenesis, site directed; myocardial contraction; receptors

Indexed keywords

BETA ADRENERGIC RECEPTOR; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE CONTRACTILITY; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 10544232615     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119086     Document Type: Article

References (46)

1. Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T.A. Stewart. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7:2609-2617.
2. Liu, J.P., J. Baker, A.S. Perkins, E.J. Robertson, and A. Efstratiadis. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
3. Baker, J., J.P. Liu, E.J. Robertson, and A. Efstratiadis. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
4. Copeland, K.C., and K.S. Nair. 1994. Recombinant human insulin-like growth factor-I increases forearm blood flow. J. Clin. Endocrinol. Metab. 79: 230-232.
5. Fryburg, D.A. 1994. Insulin-like growth factor I exerts growth hormone-and insulin-like actions on human muscle protein metabolism. Am. J. Physiol. 267:E331-E336.
6. Wahlander, H., J. Isgaard, E. Jennische, and P. Friberg. 1992. Left ventricular insulin-like growth factor I increases in early renal hypertension. Hypertension. 19:25-32.
7. Czerwinski, S.M., J. Novakofski, and P.J. Bechtel. 1993. Is insulin-like growth factor gene expression modulated during cardiac hypertrophy? Med. Sci. Sports. Exercise. 25:495-500.
8. Donohue, T.J., L.D. Dworkin, M.N. Lango, K. Fliegner, R.P. Lango, J.A. Benstein, W.R. Slater, and V.M. Catanese. 1994. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 89:799-809.
9. Duerr, R.L., S. Huang, H.R. Miraliakbar, R. Clark, K.R. Chien, and J. Ross, Jr. 1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J. Clin. Invest. 95: 619-627.
10. Cittadini, A., H. Stromer, S.E. Katz, R. Clark, A.C. Moses, J.P. Morgan, and P.S. Douglas. 1996. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 93:800-809.
11. Fazio, S., D. Sabatini, B. Capaldo, C. Vigorito, A. Giordano, R. Guida, F. Pardo, B. Biondi, and L. Sacca. 1996. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 334:809-814.
12. Rockman, H.A., R.S. Ross, A.N. Harris, K.U. Knowlton, M.E. Steinhelper, L.J. Field, J. Ross, Jr., and K.R. Chien. 1991. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 88: 8277-8281.
13. Rockman, H.A., S. Ono, R.S. Ross, L.R. Jones, M. Karimi, V. Bhargava, J.J. Ross, and K.R. Chien. 1994. Molecular and physiological alterations in murine ventricular dysfunction. Proc. Natl. Acad. Sci. USA. 91:2694-2698.
14. Chien, K.R. 1993. Molecular advances in cardiovascular biology. Science (Wash. DC). 260:916-917.
15. Chien, K.R. 1995. Cardiac muscle diseases in genetically engineered mice: evolution of molecular physiology. Am. J. Physiol. 269:H755-H766.
16. Lieberman, S.A., J. Bukar, S.A. Chen, A.C. Celniker, P.G. Compton, J. Cook, J. Albu, A.J. Perlman, and A.R. Hoffman. 1992. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans. J. Clin. Endocrinol. Metab. 75:30-36.
17. Elias, K.A., G.S. Ingle, J.P. Burnier, R.G. Hammonds, R.S. McDowell, T.E. Rawson, T.C. Somers, M.S. Stanley, and M.J. Cronin. 1995. In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology. 136:5694-5699.
18. Milano, C.A., L.F. Allen, H.A. Rockman, P.C. Dolber, T.R. McMinn, K.R. Chien, T.D. Johnson, R.A. Bond, and R.J. Lefkowitz. 1994. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science (Wash. DC). 264:582-586.
19. Koch, W.J., H.A. Rockman, P. Samama, R.A. Hamilton, R.A. Bond, C.A. Milano, and R.J. Lefkowitz. 1995. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science (Wash. DC). 268:1350-1353.
20. Bond, R.A., P. Leff, T.D. Johnson, C.A. Milano, H.A. Rockman, T.R. McMinn, S. Apparsundaram, M.F. Hyek, T.P. Kenakin, L.F. Allen et al., 1995. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature (Lond.). 374:272-276.
21. Hasty, P., J. Rivera-Perez, C. Chang, and A. Bradley. 1991. Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol. Cell. Biol. 11:4509-4517.
22. Yin, F.C., H.A. Spurgeon, K. Rakusan, M.L. Weisfeldt, and E.G. Lakatta. 1982. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am. J. Physiol. 243:H941-H947.
23. Brown, L., B. Wyse, and C. Sernia. 1993. Adrenoceptor-mediated cardiac and vascular responses in genetically growth hormone-deficient rats. Biochem. Pharmacol. 45:2223-2229.
24. Ross, J. Jr., J.W. Covell, E.H. Sonnenblick, and E. Braunwald. 1956. Contractile state of the heart characterized by force-velocity relations in variably afterloaded and isovolumic beats. Circ. Res. 18:149-163.
25. Ito, H., M. Hiroe, Y. Hirata, M. Tsujino, S. Adachi, M. Shichiri, A. Koike, A. Nogami, and F. Marumo. 1993. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 87:1715-1721.
26. Kajstura, J., W. Cheng, K. Reiss, and P. Anversa. 1994. The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellular hypertrophy in vitro. Exp. Cell. Res. 215:273-283.
27. Reiss, K., L.G. Meggs, P. Li, G. Olivetti, J.M. Capasso, and P. Anversa. 1994. Upregulation of IGF1, IGF1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J. Cell. Physiol. 158:160-168.
28. Kurtz, T.W. 1994. Genetic models of hypertension. Lancet. 344:167-168.
29. Cicila, G.T., J.P. Rapp, J.M. Wang, E. St. Lezin, S.C. Ng, and T.W. Kurtz. 1993. Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nat. Genet. 3:346-353.
30. Kim, H.S., J.H. Krege, K.D. Kluckman, J.R. Hagaman, J.B. Hodgin, C.F. Best, J.C. Jennette, T.M. Coffman, N. Maeda, and O. Smithies. 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA. 92:2735-2739.
31. John, S.W., J.H. Krege, P.M. Oliver, J.R. Hagaman, J.B. Hodgin, S.C. Pang, T.G. Flynn, and O. Smithies. 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science (Wash. DC). 267:679-681.
32. Smithies, O., and N. Maeda. 1995. Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension. Proc. Natl. Acad. Sci. USA. 92:5266-5272.
33. Hwang, D.L., L.J. Latus, and A. Lev-Ran. 1992. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I, and TGF-beta) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp. Cell. Res. 200:358-360.
34. Wu, H.Y., Y.Y. Jeng, C.J. Yue, K.Y. Chyu, W.A. Hsueh, and T.M. Chan. 1994. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes. 43:1027-1032.
35. White, M.F., and C.R. Kahn. 1994. The insulin signaling system. J. Biol. Chem. 269:1-4.
36. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 85:1844-1852.
37. Laakso, M., S.V. Edelman, G. Brechtel, and A.D. Baron. 1992. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 41:1076-1083.
38. Feldman, R.D., and G.S. Bierbrier. 1993. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet. 342:707-709.
39. Anderson, E.A., and A.L. Mark. 1993. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension. 21:136-141.
40. Haylor, J., I. Singh, and A.M. el Nahas. 1991. Nitric oxide synthesis inhibitor prevents vasodilation by insu81in-like growth factor I. Kidney Int. 39: 333-335.
41. Hirschberg, R., J.D. Kopple, R.C. Blantz, and B.J. Tucker. 1991. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J. Clin. Invest. 87:1200-1206.
42. Dilley, R.J., and S.M. Schwartz. 1989. Vascular remodeling in the growth hormone transgenic mouse. Circ. Res. 65:1233-1240.
43. Harrap, S.B., F. Macpherson, V.G. Wilson, D.L. Davies, O.P. Isaksson, B. Folkow, and A.F. Lever. 1988. Failure of chronic administration of growth hormone to affect blood pressure, vascular reactivity and sodium metabolism in normal rats. J. Hypertens. (Suppl.) 6:S170-S172.
44. Hirschberg, R., and J.D. Kopple. 1989. Effects of growth hormone and IGF-I on renal function. Kidney Int. (Suppl.):S20-S26.
45. Hadcock, J.R., J.D. Port, M.S. Gelman, and C.C. Malbon. 1992. Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. J. Biol. Chem. 267:26017-26022.
46. Luo, W., I.L. Grupp, J. Harrer, S. Ponniah, G. Grupp, J.J. Duffy, T. Doetschman, and E.G. Kranias. 1994. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 75:401-409.